Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
CPSE:NOVO B
Novo Nordisk A/S
|
917.10 | -2,55% | 17,67% | 4.085.530,55 | 1,03% | 18,5% |
|
NYSE:MRK
Merck
|
131.73 | -10,39% | 2,75% | 333.646,57 | 2,39% | -19,03% |
|
LSE:AZN
AstraZeneca PLC
|
121.72 | 18,28% | 40,89% | 188.694,61 | 2,01% | 15,98% |
|
NasdaqGS:AMGN
Amgen
|
319.04 | -14,06% | -5,45% | 171.144,12 | 2,89% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.82 | 7,74% | 37,79% | 163.311,21 | 5,92% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
90.56 | 17,5% | 36,18% | 113.210,59 | 4,1% | 8,19% |
|
ASX:CSL
CSL
|
283.05 | 21,27% | 41,99% | 136.784,68 | 1,27% | 7,18% |
|
NasdaqGS:BIIB
Biogen
|
235.32 | -16,94% | -2,2% | 34.261,86 | 0% | -10,89% |
|
XTRA:BAYN
Bayer
|
29.33 | 63,25% | 79,18% | 28.809,59 | 0,38% | 1,47% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
80.40 | 142,2% | 221,62% | 15.385,96 | 0% | 32,46% |
|
NasdaqGS:RIGL
Rigel Pharmaceuticals
|
0.97 | 0% | 0% | 208,7 | 0% | 0% |
